Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Molidustat - Bayer HealthCare Pharmaceuticals

Next Previous
X
Search
Drug Profile

Molidustat - Bayer HealthCare Pharmaceuticals

Alternative Names: BAY-1053048; BAY-853934; HIF-PH inhibitor - Bayer; Hypoxia-inducible factor-prolyl hydroxylase inhibitor - Bayer; Molidustat sodium - Bayer HealthCare Pharmaceuticals; Musredo

Latest Information Update: 25 Sep 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer Schering Pharma
  • Developer Bayer HealthCare Pharmaceuticals
  • Class Antianaemics; Morpholines; Pyrazoles; Pyrazolones; Pyrimidines; Small molecules; Triazoles
  • Mechanism of Action Hypoxia-inducible factor-proline dioxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Anaemia

Most Recent Events

  • 25 Sep 2024 Chemical structure information added.
  • 09 Sep 2024 Discontinued - Phase-II for Anaemia in Israel, Turkey, Spain, France, Poland, Germany, United Kingdom, Romania, South Korea, Italy, Bulgaria, Bulgaria, Australia, USA, Hungary (PO) prior to September 2024 (Bayer HealthCare Pharmaceuticals pipeline, September 2024)
  • 22 Jan 2021 Preregistration for Anaemia in Japan (PO) before April 2020

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top